Carbetocin versus Oxytocin for prevention of postpartum hemorrhage at cesarean sectio

Phase 3

Completed

• Conditions: postpartum hemorrhage.; Postpartum care and examination

• Registration Number: IRCT2015050919644N1
• Lead Sponsor: Vice Chancellor for research, Zahedan University of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 90

Inclusion Criteria

Pregnant women with single pregnancy one previous cesarean section or primary cesarean and candidate for cesarean delivery & application of spinal anesthesia.
5-Exclusion criteria: Other reason of PPH except atonia; Presence of preeclampsia; hypotension; heart disease and asthma; Presence of risk factor of PPH such as uterine fibroid? previous myomectomy? placenta previa? past history of PPH? chorioamnionitis; fetal macrosomia and fetal malformations associated with polyhydramnios

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemoglobin level. Timepoint: Before and 6 and 12hours after cesarean delivery. Method of measurement: Hemoglobine assessment.

Secondary Outcome Measures

Name	Time	Method
terine tone. Timepoint: 2 and 12 and 24 hours after cesarean delivery. Method of measurement: Assessment of uterine tone.;Need to adminestration of utertonic drug. Timepoint: During 24 hours after cesarean delivery. Method of measurement: Dosage and amount of drug.;Adverse effects. Timepoint: During 24 hours after cesarean delivery. Method of measurement: Observation of adverse effects.